Abstract

Live-attenuated strains of simian immunodeficiency virus (SIV) routinely confer apparent sterilizing immunity against pathogenic SIV challenge in rhesus macaques. Understanding the mechanisms of protection by live-attenuated SIV may provide important insights into the immune responses needed for protection against HIV-1. Here we investigated the development of antibodies that are functional against neutralization-resistant SIV challenge strains, and tested the hypothesis that these antibodies are associated with protection. In the absence of detectable neutralizing antibodies, Env-specific antibody-dependent cell-mediated cytotoxicity (ADCC) emerged by three weeks after inoculation with SIVΔnef, increased progressively over time, and was proportional to SIVΔnef replication. Persistent infection with SIVΔnef elicited significantly higher ADCC titers than immunization with a non-persistent SIV strain that is limited to a single cycle of infection. ADCC titers were higher against viruses matched to the vaccine strain in Env, but were measurable against viruses expressing heterologous Env proteins. In two separate experiments, which took advantage of either the strain-specificity or the time-dependent maturation of immunity to overcome complete protection against SIVmac251 challenge, measures of ADCC activity were higher among the SIVΔnef-inoculated macaques that remained uninfected than among those that became infected. These observations show that features of the antibody response elicited by SIVΔnef are consistent with hallmarks of protection by live-attenuated SIV, and reveal an association between Env-specific antibodies that direct ADCC and apparent sterilizing protection by SIVΔnef.

Highlights

  • The development of a vaccine against HIV-1 continues to be hampered by our limited understanding of the types of immune responses needed for protection

  • Our results suggest that antibodies contribute to protection by live-attenuated simian immunodeficiency virus (SIV), and that persistent stimulation of antibody responses may be essential for HIV-1 vaccines to induce high antibody-dependent cell-mediated cytotoxicity (ADCC) activity

  • Time-dependent maturation of antibody responses Plasma samples collected at longitudinal time points after inoculation with SIVmac239Dnef were tested for their ability to neutralize SIVmac239 and to direct ADCC against SIVmac239infected cells

Read more

Summary

Introduction

The development of a vaccine against HIV-1 continues to be hampered by our limited understanding of the types of immune responses needed for protection. Identifying the immune responses that mediate protection by live-attenuated SIV and understanding how to elicit them by vaccination may provide important insights for the development of a safe and effective HIV-1 vaccine [10]. T cell, and innate immunity have evolved to operate synergistically as an integrated system [11,12,13], and a combination of these immune responses may be necessary for complete protection by live-attenuated SIV. Antibodies capable of neutralizing virus infectivity develop over time through affinity maturation [18,19,20,21].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call